Renaissance Technologies
TPI

Renaissance Technologies’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Renaissance Technologies’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-827,600
Closed -$124K – 3708
2016
Q1 		$124K Buy
827,600
+24,800
+3% +$3.3K ﹤0.01% 3180
2015
Q4 		$134K Buy
802,800
+11,500
+1% +$2.5K ﹤0.01% 3070
2015
Q3 		$174K Buy
791,300
+11,700
+2% +$3.54K ﹤0.01% 2922
2015
Q2 		$365K Buy
779,600
+8,000
+1% +$3.65K ﹤0.01% 2812
2015
Q1 		$347K Buy
771,600
+33,700
+5% +$19.1K ﹤0.01% 2711
2014
Q4 		$539K Buy
737,900
+23,500
+3% +$12.9K ﹤0.01% 2403
2014
Q3 		$457K Buy
714,400
+34,300
+5% +$21.7K ﹤0.01% 2341
2014
Q2 		$490K Buy
680,100
+60,000
+10% +$47.4K ﹤0.01% 2331
2014
Q1 		$609K Buy
620,100
+131,400
+27% +$132K ﹤0.01% 2272
2013
Q4 		$387K Buy
488,700
+78,200
+19% +$71.8K ﹤0.01% 2437
2013
Q3 		$308K Buy
410,500
+12,200
+3% +$8.05K ﹤0.01% 2462
2013
Q2 		$196K Buy
+398,300
New +$234K ﹤0.01% 2521

Other funds holding TPI

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return

Renaissance Technologies's TPI Position: Q2 2016 in Review

Renaissance Technologies sold out of TIANYIN PHARMACEUTICAL (TPI) in Q2 2016, closing a stake of 827,600 shares — an estimated $124K sold.

Renaissance Technologies first reported a position in TPI in Q2 2013 and held it in 12 quarters. The position peaked at $609K in Q1 2014. 2 funds tracked by Wall St. Rank hold TPI as of Q2 2016.

  • Renaissance Technologies reported no remaining TIANYIN PHARMACEUTICAL position as of Q2 2016 after selling out during the quarter.
  • Renaissance Technologies sold 827,600 TIANYIN PHARMACEUTICAL shares in Q2 2016, an estimated $124K.
  • Renaissance Technologies first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and held it in 12 quarters.
  • Renaissance Technologies's TIANYIN PHARMACEUTICAL position peaked at $609K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q2 2016.

Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.